The time-dependent shift in the hepatic graft and recipient macrophage pool following liver transplantation

Haitao Huang¹, Xueyou Zhang¹, Cheng Zhang¹, Hui Chen², Qi Ling^{3

4}, Shusen Zheng^{5

6}

Affiliations

¹ Department of Surgery, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, China.
³ Department of Surgery, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. lingqi@zju.edu.cn.
⁴ Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, China. lingqi@zju.edu.cn.
⁵ Department of Surgery, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. zyzss@zju.edu.cn.
⁶ Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, China. zyzss@zju.edu.cn.

Haitao Huang et al. Cell Mol Immunol. 2020 Apr.

. 2020 Apr;17(4):412-414.

doi: 10.1038/s41423-019-0253-x. Epub 2019 Jun 26.

Haitao Huang¹, Xueyou Zhang¹, Cheng Zhang¹, Hui Chen², Qi Ling^{3

4}, Shusen Zheng^{5

6}

¹ Department of Surgery, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, China.
³ Department of Surgery, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. lingqi@zju.edu.cn.
⁴ Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, China. lingqi@zju.edu.cn.
⁵ Department of Surgery, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. zyzss@zju.edu.cn.
⁶ Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, China. zyzss@zju.edu.cn.

No abstract available

Conflict of interest statement

The authors declare no competing interests.

1. Ling Q, et al. Donor graft microRNAs: a newly identified player in the development of new-onset diabetes after liver transplantation. Am. J. Transpl. 2017;17:255–264. doi: 10.1111/ajt.13984. - DOI - PMC - PubMed
1. Xu X, et al. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population. Int. J. Cancer. 2016;138:620–629. doi: 10.1002/ijc.29821. - DOI - PubMed
1. Dunn W, et al. Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C. Hepatology. 2014;59:453–460. doi: 10.1002/hep.26758. - DOI - PMC - PubMed
1. John BV, et al. Recipient but not donor adiponectin polymorphisms are associated with early posttransplant hepatic steatosis in patients transplanted for non-nonalcoholic fatty liver disease indications. Exp. Clin. Transpl. 2018;16:439–445. - PubMed
1. Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat. Rev. Immunol. 2017;17:306–321. doi: 10.1038/nri.2017.11. - DOI - PubMed